- Home
- CWD vs ELAB Comparison
CWD vs ELAB Comparison
Compare CWD & ELAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWD
- ELAB
- Stock Information
- Founded
- CWD 2009
- ELAB 2020
- Country
- CWD United States
- ELAB United States
- Employees
- CWD N/A
- ELAB N/A
- Industry
- CWD Real Estate
- ELAB
- Sector
- CWD Finance
- ELAB
- Exchange
- CWD Nasdaq
- ELAB Nasdaq
- Market Cap
- CWD 6.2M
- ELAB 6.6M
- IPO Year
- CWD 2023
- ELAB 2023
- Fundamental
- Price
- CWD $3.85
- ELAB $2.47
- Analyst Decision
- CWD
- ELAB
- Analyst Count
- CWD 0
- ELAB 0
- Target Price
- CWD N/A
- ELAB N/A
- AVG Volume (30 Days)
- CWD 48.2K
- ELAB 711.3K
- Earning Date
- CWD 05-15-2025
- ELAB 05-23-2025
- Dividend Yield
- CWD N/A
- ELAB N/A
- EPS Growth
- CWD N/A
- ELAB N/A
- EPS
- CWD N/A
- ELAB N/A
- Revenue
- CWD $51,119,000.00
- ELAB N/A
- Revenue This Year
- CWD N/A
- ELAB N/A
- Revenue Next Year
- CWD $35.72
- ELAB N/A
- P/E Ratio
- CWD N/A
- ELAB N/A
- Revenue Growth
- CWD N/A
- ELAB N/A
- 52 Week Low
- CWD $4.00
- ELAB $2.14
- 52 Week High
- CWD $20.80
- ELAB $980.00
- Technical
- Relative Strength Index (RSI)
- CWD 28.27
- ELAB 37.57
- Support Level
- CWD $3.75
- ELAB $2.37
- Resistance Level
- CWD $4.46
- ELAB $2.55
- Average True Range (ATR)
- CWD 0.67
- ELAB 0.22
- MACD
- CWD 0.14
- ELAB 0.15
- Stochastic Oscillator
- CWD 10.09
- ELAB 31.13
About CWD CaliberCos Inc.
CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.